MJ

Ming-Kuei Jang

Cofounder & CEO at APRINOIA Therapeutics

China, China

About

Alzheimer drug discovery consortium, MD Anderson Cancer Center, Houston Associate Director, GlaxoSmithKline, Shanghai Senior Research Biologist, Merck & CO, Boston Postdoc in Neurophysiology at Northwestern University and Columbia University Ph.D in Pharmacology and Neuroscience, Boston University BS in Chemistry, National Taiwan University, Taiwan Neurodegenerative diseases; synaptic functions; novel biomarker discovery

Position in the VCSift Database

  • 27 investors hold the Cofounder & CEO role in VCSift. Ming-Kuei Jang is one of them.
  • 110 investors are based in China.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Location
China

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Ming-Kuei

Search Investors